Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chee-Seng Yee

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|September 26, 2009
Numerical scoring for the Classic BILAG indexLynne Cresswell, Chee-Seng Yee, Vernon Farewell, et al.
Rheumatology (Oxford, England)|June 10, 2022
The BILAG-2004 index is associated with development of new damage in SLEChee-Seng Yee, Caroline Gordon, Mohammed Akil, et al.
Rheumatology (Oxford, England)|April 1, 2021
Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre studyKhaled Mahmoud, Ahmed S Zayat, Md Yuzaiful Md Yusof, et al.
Arthritis and Rheumatism|September 30, 2006
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Rheumatology (Oxford, England)|April 13, 2021
Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scopeIan Giles, Alexander Allen, Amy Crossley, et al.
Rheumatology (Oxford, England)|April 22, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Rheumatology (Oxford, England)|May 27, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Rheumatology (Oxford, England)|November 1, 2022
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2022
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|September 26, 2009
Numerical scoring for the Classic BILAG indexLynne Cresswell, Chee-Seng Yee, Vernon Farewell, et al.
Rheumatology (Oxford, England)|June 10, 2022
The BILAG-2004 index is associated with development of new damage in SLEChee-Seng Yee, Caroline Gordon, Mohammed Akil, et al.
Rheumatology (Oxford, England)|April 1, 2021
Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre studyKhaled Mahmoud, Ahmed S Zayat, Md Yuzaiful Md Yusof, et al.
Arthritis and Rheumatism|September 30, 2006
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Rheumatology (Oxford, England)|April 13, 2021
Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scopeIan Giles, Alexander Allen, Amy Crossley, et al.
Rheumatology (Oxford, England)|April 22, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Rheumatology (Oxford, England)|May 27, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Rheumatology (Oxford, England)|November 1, 2022
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2022
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practiceKaren Schreiber, Margreta Frishman, Mark D Russell, et al.
Rheumatology (Oxford, England)|December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Pageof 4